about
Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system functionBiomarker discovery based on BBHA and AdaboostM1 on microarray data for cancer classification.Global gene expression analysis of reactive stroma in prostate cancer.Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.Genetic alterations in human prostate cancer: a review of current literature.miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer.Interleukin-6 is an autocrine growth factor in human prostate cancer.The role of fibroblast growth factors and their receptors in prostate cancer.Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertensionNovel MASP1 mutations are associated with an expanded phenotype in 3MC1 syndromeA Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets.Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.The function of microRNAs, small but potent molecules, in human prostate cancer.Current status of the use of single-nucleotide polymorphisms in forensic practices.The role of miRNAs in cancer: from pathogenesis to therapeutic implications.Widespread deregulation of microRNA expression in human prostate cancer.Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.Novel POC1A mutation in primordial dwarfism reveals new insights for centriole biogenesis.The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells.The altered promoter methylation of oxytocin receptor gene in autism.Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.A novel method for splice sites prediction using sequence component and hidden Markov model.MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients.The role of ATP-binding cassette transporter genes in the progression of prostate cancer.Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.Revealing the function of a novel splice-site mutation of CHD7 in CHARGE syndrome.Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer.Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity.Dolastatin-10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line.Establishment of an in vitro cell model system to study human prostate carcinogenesis.miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer.A novel frameshift mutation and infrequent clinical findings in two cases with Dyggve-Melchior-Clausen syndrome.Hypoxic adipocytes pattern early heterotopic bone formation.Genomic profiling of prostate cancers from African American men.A rare case of split hand/foot malformation with sensorineural hearing loss and Mondini dysplasia.Hormones, Genes, and Cancer.Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor.Whole-exome sequencing revealed two novel mutations in Usher syndrome.Differential expression of LOXL4 in normal and tumour tissue samples of laryngeal squamous cell carcinoma.
P50
Q24295194-1176E9D2-898D-4EB1-A3AC-A85468C618BEQ31171799-10D05A48-D430-4C49-9096-A471C31EEDEBQ33464811-9BF9E69E-681A-4F94-8D30-CF783D406B94Q33834711-7F86A2D8-F13B-4DAF-A0C0-39236465D382Q33992144-6CA579E0-07DA-467F-85BF-9CF711D48803Q35195342-12754C7E-C32D-4E3F-866A-07C6A1E72401Q35747214-E0191F63-8F84-4D6D-A832-FB6B00365858Q35991012-67732BFA-7B70-4A12-835D-F2CE1B665179Q36009129-3CFA08FE-B659-4A96-9BC2-6FC592544108Q36108339-C857B1D9-8476-428C-B31F-B5B26D74C31CQ36140097-E86DA154-62FB-4FE5-A99C-2AB7B1834533Q36183477-B06C6ADA-B726-413F-BDB9-03F7AC3C0CD2Q36775218-E9A7D365-C482-432D-AF6C-EBC9D5F876E3Q37768337-E6EB0944-8A85-44CE-B9EE-226AAAC50181Q38206225-238AD1E1-A4B3-4D15-A912-2C831F3DF26DQ38221290-315684F3-673F-4F69-9E98-51EFA17F2335Q38297946-84DD75C6-A5E1-4B0A-A338-DD5E3D7FE806Q38349736-704A3B11-568E-4E3C-A193-A807D9B2B795Q38545042-A3B0855F-B2E7-46D2-BA86-D9F78E3BA1D2Q38826011-AD3CE4D3-E9BA-4D76-9285-75FB4818EDD6Q38852303-6AE3A871-467C-4283-A895-651822083AF1Q38878117-6489BEF1-39E3-4785-962F-8187F8941221Q38923720-AB07CACF-D51B-4D17-94D9-FEC27A67C60BQ39423877-609786F4-AB53-4E7B-B6FD-614640EA162BQ40167077-741DF43A-99BA-4985-B113-00A6780BB3EAQ40209622-0D3E6CC9-8FE2-45D0-BFA8-633FE99FA373Q40341446-D85FA183-603A-4148-BBC6-A3186ADC6698Q40401176-FE7D626B-8B0B-4133-A719-D18FCD4C6E6CQ40986018-FBB47521-8CBF-41FA-9B4F-4A12A6B5E89AQ41051161-14796AFF-FBD3-420B-8E3B-8F4BBAFC216FQ41199927-F8C1256A-FE00-4580-87EB-BD090FD9A714Q41694147-324A142E-1F09-4163-A501-F9C763C876F9Q41931005-28779A95-7734-49C7-A3C7-8355C0E18B32Q42853387-AF672940-76E1-4FCF-900A-EF04B5F86454Q43174336-98668DEF-41BE-43B7-894C-AEC244C5554CQ44416762-0F03F2D6-7866-44A1-809E-500ABCE0DC8DQ46886908-4E2D7C39-88D3-467E-A0EC-3815632DD034Q47746353-4804C3C7-B984-41C9-9664-143345942E5CQ50352760-CBF20BB3-0CDA-4DAF-914B-A5D5EE227B0FQ50540766-729F8E0F-8333-440F-8902-AFE700F0940A
P50
description
researcher
@en
wetenschapper
@nl
name
Mustafa Ozen
@en
Ozen M
@nl
type
label
Mustafa Ozen
@en
Ozen M
@nl
altLabel
Ozen M
@en
prefLabel
Mustafa Ozen
@en
Ozen M
@nl
P106
P31
P496
0000-0002-6142-5294